Scarica l'app Stockscreener
12.94
1.90%
-0.25
Dopo l'orario di chiusura:
12.96
0.02
+0.15%
Precedente Chiudi:
$13.19
Aprire:
$13.11
Volume 24 ore:
29,825
Relative Volume:
0.87
Capitalizzazione di mercato:
$170.09M
Reddito:
-
Utile/perdita netta:
$-8.89M
Rapporto P/E:
-18.49
EPS:
-0.7
Flusso di cassa netto:
$-6.48M
1 W Prestazione:
-1.15%
1M Prestazione:
+15.23%
6M Prestazione:
-19.73%
1 anno Prestazione:
+49.77%
Intervallo 1D:
$12.90
$13.60
Intervallo di 1 settimana:
$12.71
$14.41
Portata 52W:
$8.00
$21.44
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Nome
Greenwich Lifesciences Inc
Settore
Industria
Telefono
203-434-3290
Indirizzo
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Confronta GLSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
12.94 | 170.09M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-01 | Iniziato | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Borsa (GLSI) Ultime notizie
EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial - Yahoo Finance
Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial - Marketscreener.com
Greenwich LifeSciences stock gains on approval to add additional sites to Flamingo-01 in Europe - MSN
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe - GlobeNewswire
Major Breakthrough: Cancer Prevention Trial Goes Europe-Wide as Top Medical Centers Join Forces - StockTitan
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland - GlobeNewswire
Greenwich LifeSciences Expands Phase III Breast Cancer Trial Across Poland - StockTitan
How to Take Advantage of moves in (GLSI) - Stock Traders Daily
Barclays PLC Has $123,000 Stake in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World
Bullish Greenwich LifeSciences Insiders Loaded Up On US$3.39m Of Stock - Yahoo Finance
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 - GlobeNewswire
Harvard, Johns Hopkins Join Greenwich LifeSciences' Phase III Breast Cancer Vaccine Trial - StockTitan
Greenwich LifeSciences stock gains on GP2 update (GLSI) - Seeking Alpha
Greenwich LifeSciences Provides Update on Commercial Manufacturing - GlobeNewswire
Greenwich LifeSciences Achieves Major Manufacturing Milestone for Breast Cancer Immunotherapy GP2 - StockTitan
Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI) - Marketscreener.com
Long Term Trading Analysis for (GLSI) - Stock Traders Daily
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01 - GlobeNewswire
Greenwich LifeSciences expands trial sites in Germany - Investing.com India
Greenwich Lifesciences Announces Partnership with GBG in Germany for Flamingo-01 - Marketscreener.com
Greenwich LifeSciences CEO acquires $31,275 in common stock By Investing.com - Investing.com Australia
Greenwich LifeSciences CEO acquires $31,275 in common stock - Investing.com India
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Buys 2,500 Shares - MarketBeat
Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus.com
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France - The Manila Times
Greenwich LifeSciences Expands Phase III Breast Cancer Trial Across France with Unicancer Network - StockTitan
Geode Capital Management LLC Raises Stock Holdings in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World
Barclays PLC Increases Position in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World
Greenwich Lifesciences CEO Snehal Patel buys $39,391 in stock By Investing.com - Investing.com Australia
Insider Buying: Snehal Patel Increases Stake in Greenwich LifeSc - GuruFocus.com
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $24,750.00 in Stock - MarketBeat
Greenwich Lifesciences CEO Snehal Patel buys $39,391 in stock - Investing.com India
Greenwich Lifesciences CEO Snehal Patel acquires $44,030 in stock By Investing.com - Investing.com Canada
Greenwich Lifesciences CEO Snehal Patel acquires $44,030 in stock - Investing.com
Greenwich LifeSciences CEO Snehal Patel buys $23,940 in stock By Investing.com - Investing.com Australia
Snehal Patel Buys 2,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock - MarketBeat
Greenwich LifeSciences CEO Snehal Patel buys $23,940 in stock - Investing.com India
(GLSI) Trading Report - Stock Traders Daily
Greenwich LifeSciences CEO buys $27,264 in company stock By Investing.com - Investing.com Australia
Greenwich LifeSciences CEO buys $27,264 in company stock - Investing.com India
State Street Corp Raises Holdings in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World
Greenwich Lifesciences CEO Snehal Patel acquires $35,584 in stock By Investing.com - Investing.com Canada
Snehal Patel Purchases 3,200 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock - MarketBeat
Greenwich Lifesciences CEO Snehal Patel acquires $35,584 in stock - Investing.com India
Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):